Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia: A Study Protocol for a Single-Center, Randomized, Placebo-Controlled Trial

NCT07613138 is registered in ClinicalTrials.gov with Beijing Zhecheng Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07613138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07613138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia: A Study Protocol for a Single-Center, Randomized, Placebo-Controlled Trial
Lead sponsor
Beijing Zhecheng Biotechnology Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 4, 2026
Completion date
May 1, 2028
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia with or without gout